WO2021025017A1 - 細胞凍結前処理作業用プレート - Google Patents

細胞凍結前処理作業用プレート Download PDF

Info

Publication number
WO2021025017A1
WO2021025017A1 PCT/JP2020/029814 JP2020029814W WO2021025017A1 WO 2021025017 A1 WO2021025017 A1 WO 2021025017A1 JP 2020029814 W JP2020029814 W JP 2020029814W WO 2021025017 A1 WO2021025017 A1 WO 2021025017A1
Authority
WO
WIPO (PCT)
Prior art keywords
circular
recess
compartment
treatment liquid
cell
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Ceased
Application number
PCT/JP2020/029814
Other languages
English (en)
French (fr)
Japanese (ja)
Inventor
井上 太
恵一 加藤
晶子 藪内
智 上野
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Kitazato Corp
Original Assignee
Kitazato Corp
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Kitazato Corp filed Critical Kitazato Corp
Priority to EP20850279.9A priority Critical patent/EP4012013A4/en
Priority to JP2021537319A priority patent/JP7607339B2/ja
Publication of WO2021025017A1 publication Critical patent/WO2021025017A1/ja
Priority to US17/592,785 priority patent/US12402620B2/en
Anticipated expiration legal-status Critical
Ceased legal-status Critical Current

Links

Images

Classifications

    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/12—Chemical aspects of preservation
    • A01N1/122—Preservation or perfusion media
    • A01N1/125—Freeze protecting agents, e.g. cryoprotectants or osmolarity regulators
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/142—Apparatus
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M45/00—Means for pre-treatment of biological substances
    • C12M45/22—Means for packing or storing viable microorganisms
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/14—Mechanical aspects of preservation; Apparatus or containers therefor
    • A01N1/146—Non-refrigerated containers specially adapted for transporting or storing living parts whilst preserving
    • A01N1/147—Carriers for immersion in cryogenic fluid for slow freezing or vitrification
    • A—HUMAN NECESSITIES
    • A01—AGRICULTURE; FORESTRY; ANIMAL HUSBANDRY; HUNTING; TRAPPING; FISHING
    • A01N—PRESERVATION OF BODIES OF HUMANS OR ANIMALS OR PLANTS OR PARTS THEREOF; BIOCIDES, e.g. AS DISINFECTANTS, AS PESTICIDES OR AS HERBICIDES; PEST REPELLANTS OR ATTRACTANTS; PLANT GROWTH REGULATORS
    • A01N1/00—Preservation of bodies of humans or animals, or parts thereof
    • A01N1/10—Preservation of living parts
    • A01N1/16—Physical preservation processes
    • A01N1/162—Temperature processes, e.g. following predefined temperature changes over time
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M21/00—Bioreactors or fermenters specially adapted for specific uses
    • C12M21/06—Bioreactors or fermenters specially adapted for specific uses for in vitro fertilization
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12M—APPARATUS FOR ENZYMOLOGY OR MICROBIOLOGY; APPARATUS FOR CULTURING MICROORGANISMS FOR PRODUCING BIOMASS, FOR GROWING CELLS OR FOR OBTAINING FERMENTATION OR METABOLIC PRODUCTS, i.e. BIOREACTORS OR FERMENTERS
    • C12M99/00—Subject matter not otherwise provided for in other groups of this subclass

Definitions

  • the present invention relates to a cell freeze pretreatment working plate used for cryopreserving living cells such as mammalian eggs, eggs such as embryos, sperms, hematopoietic stem cells, and stem cells such as pluripotent stem cells.
  • Cryopreservation of mammalian embryos enables the preservation of genetic resources of specific strains and varieties. It is also effective in maintaining endangered animal species. It is also useful in the treatment of human infertility.
  • Patent Document 1 As a method for cryopreserving a mammalian embryo, in Japanese Patent Application Laid-Open No. 2000-189155 (Patent Document 1), a cryopreservation container such as a frozen straw, a frozen vial, or a frozen tube obtained by sterilizing a mammalian embryo or an egg is provided on the inner surface of a cryopreservation container. It has been proposed to apply a minimal vitrifying solution sufficient to cover these embryos or eggs, seal the cryopreservation vessel, and bring the vessel into contact with liquid nitrogen for rapid cooling. There is.
  • Patent Document 1 a method for cryopreserving a mammalian embryo, in Japanese Patent Application Laid-Open No. 2000-189155 (Patent Document 1), a cryopreservation container such as a frozen straw, a frozen vial, or a frozen tube obtained by sterilizing a mammalian embryo or an egg is provided on the inner surface of a cryopreservation container. It has been proposed to apply a minimal vitrifying solution sufficient
  • Patent Document 2 Japanese Patent Laid-Open No. 2002-315573, WO 02-085101 A1.
  • the egg cryopreservation tool 1 of Patent Document 2 is attached to a main body 2 formed of a cold-resistant material and one end of the main body 2 to hold eggs attached and retained by a flexible, transparent and liquid nitrogen-resistant material.
  • the strip 3 is composed of a tubular member 4 having one end closed and made of a cold-resistant material so that the strip 3 for holding eggs adheres and can be detachably attached to the main body 2.
  • Patent Document 3 proposes a cell treatment container for use in cell treatment using a treatment solution, such as treatment of embryos immediately before transplantation.
  • JP 2000-189155 JP-A-2002-315573 (WO 02-08511A1) JP-A-2017-118884 (WO 2016-190322 A1)
  • the vitrification preservation method utilizes the principle that ice crystals are less likely to form even below freezing point due to the freezing point depression of an aqueous solution containing a freezing agent such as glycerol or ethylene glycol.
  • a freezing agent such as glycerol or ethylene glycol.
  • this solution is rapidly cooled in liquid nitrogen, it can be solidified without forming ice crystals, and the water becomes a glassy solid without crystallizing, which is called vitrification.
  • Egg pretreatment is required to freeze the eggs by the vitrification method.
  • the processing container of Patent Document 3 is not a container for pretreatment for vitrification freezing, but a container for processing embryos immediately before transplantation.
  • An object of the present invention is to provide a cell freezing pretreatment working plate that can easily perform pretreatment for vitrification freezing with few mistakes in the procedure.
  • a plate for cell freezing pretreatment work includes a working flat plate portion, a first recess for storing a low-concentration treatment liquid containing a cell membrane-permeable cryoprotectant at a low concentration, and cell membrane permeability.
  • a second recess for storing a high-concentration treatment liquid containing a high concentration of cryoprotectant a third recess for storing a high-concentration treatment liquid containing a high concentration of cell membrane-permeable cryoprotectant, and disposal.
  • a fourth recess for storing the liquid, and further, on the surface of the working flat plate portion, a first circular compartment for placing the treatment liquid containing no cell membrane permeable cryoprotectant and the low concentration thereof.
  • a second circular compartment for placing the treatment liquid and a third circular compartment for placing the low-concentration treatment liquid are provided, and the first circular compartment and the second circular compartment are provided.
  • the compartment and the third circular compartment are close to each other, and further, on the surface of the working flat plate portion, an enlarged first circular compartment surrounding the first circular compartment and an enlarged first circular compartment are formed.
  • a plate for cell freeze pretreatment work having an enlarged second circular compartment surrounding the second circular compartment and an enlarged third circular compartment surrounding the third circular compartment.
  • a plate for cell freezing pretreatment work includes a working flat plate portion, a first recess for storing a treatment liquid, a second recess for storing the treatment liquid, and a third recess for storing the treatment liquid.
  • the concave portion and the fourth concave portion for storing the waste treatment liquid are further provided, and on the surface of the working flat plate portion, a first circular partition portion for placing the treatment liquid and a treatment liquid placement portion are provided.
  • the second circular section and the third circular section for placing the treatment liquid are provided, and the first circular section, the second circular section, and the third circle are provided.
  • the shaped compartments are close to each other, and on the surface of the working flat plate, an enlarged first circular compartment surrounding the first circular compartment and the second circular compartment and the second circular compartment are on the surface.
  • a cell freeze pretreatment work plate having an enlarged second circular compartment surrounding the third circular compartment and an enlarged third circular compartment surrounding the third circular compartment.
  • FIG. 1 is a front view of a cell freeze pretreatment work plate having a basic configuration of the cell freeze pretreatment work plate of the present invention.
  • FIG. 2 is a cross-sectional view taken along the line AA of FIG.
  • FIG. 3 is a cross-sectional view taken along the line BB of FIG.
  • FIG. 4 is a perspective view of the cell freezing pretreatment working plate shown in FIG.
  • FIG. 5 is a front view of the cell freezing pretreatment working plate shown in FIG. 1 covered with a lid.
  • FIG. 6 is a perspective view of a lid covered with the cell freezing pretreatment working plate shown in FIG.
  • FIG. 7 is an enlarged view of a flat plate portion of the cell freezing pretreatment working plate shown in FIG. FIG.
  • FIG. 8 is an enlarged cross-sectional view taken along the line CC of FIG.
  • FIG. 9 is an enlarged cross-sectional view taken along the line DD of FIG.
  • FIG. 10 is a front view of another example cell freeze pretreatment plate having the basic configuration of the cell freeze pretreatment plate of the present invention.
  • FIG. 11 is a front view of another example cell freeze pretreatment plate having the basic configuration of the cell freeze pretreatment plate of the present invention.
  • FIG. 12 is a front view of the cell freezing pretreatment working plate of the embodiment of the present invention.
  • FIG. 13 is a front view of the cell freeze pretreatment working plate of another embodiment of the present invention.
  • FIG. 14 is a front view of a cell freezing pretreatment working plate of another embodiment of the present invention.
  • the cell freeze pretreatment work plate provided with the basic configuration of the cell freeze pretreatment work plate of the present invention is a low-concentration treatment liquid containing a work plate portion 2 and a cell membrane-permeable cryoprotectant at a low concentration.
  • a first recess 14 for storage a second recess 15 for storing a high-concentration treatment liquid containing a high concentration of a cell membrane-permeable cryoprotectant, and a high concentration of a cell membrane-permeable cryoprotectant.
  • a third recess 16 for storing the high-concentration treatment liquid and a fourth recess 18 for storing the waste liquid are provided, and the surface of the working flat plate portion 2 is a treatment liquid containing no cell membrane-permeable cryoprotectant.
  • a first circular section 21 for mounting, a second circular section for placing a low-concentration treatment liquid, and a third circular section for placing a low-concentration treatment liquid are provided.
  • the first circular section 21, the second circular section 22, and the third circular section 23 are close to each other.
  • the cell freeze pretreatment work plate provided with the basic configuration of the cell freeze pretreatment work plate of the present invention may be as follows.
  • the cell freezing pretreatment work plate of this embodiment has a working flat plate portion 2, a first recess 14 for storing the treatment liquid, a second recess 15 for storing the treatment liquid, and a first recess for storing the treatment liquid.
  • the recess 16 of 3 and the fourth recess 18 for storing the waste treatment liquid are provided, and further, the surface of the working flat plate portion 2 is provided with a first circular compartment 21 for placing the treatment liquid and treatment.
  • a second circular compartment 22 for liquid placement and a third circular compartment 23 for processing liquid placement are provided, and a first circular compartment 21 and a second circular compartment 22 are provided. And the third circular section 23 is close to each other.
  • cell freeze pretreatment work plate provided with the basic configuration of the cell freeze pretreatment work plate of the present invention may be as follows.
  • the cell freezing pretreatment work plate has a working flat plate portion 2, a first recess 14 for storing the treatment liquid, a second recess 15 for storing the treatment liquid, and a third recess for storing the treatment liquid. 16 and a fourth recess 18 for storing the waste treatment liquid are provided, and further, on the surface of the working flat plate portion 2, a first circular compartment 21 for placing the treatment liquid and a treatment liquid placement portion 21 are provided. A second circular section 22 for use and a third circular section 23 for placing the treatment liquid are provided, and the first circular section 21, the second circular section 22 and the third circular section 23 are provided.
  • the circular compartments 23 of the above are close to each other, and the working flat plate portion 2 has a first display having a treatment liquid name and a loading amount display to be mounted on the first circular compartment 21.
  • Section 26 a second display section 27 having a treatment liquid name and a loading amount display placed on the second circular section 22, and a treatment solution placed on the third circular section 23.
  • a fourth display unit 28 having a name and a placement amount display, and further, the cell freezing pretreatment work plate 1 has a treatment liquid name and a storage amount display stored in the first recess 14. It has a display unit 29 of.
  • the cell freezing pretreatment work plate 1 shown in FIGS. 1 to 4 has a lower annular wall 4, an annular side wall 3 extending above the lower annular wall 4, a bottom portion 6 located in the annular side wall 3, and a lower annular wall. It is provided with an upper surface portion 12 provided at one end portion of 4. Further, in the plate 1 of this embodiment, the lower annular wall 4 has a substantially rectangular shape, is larger than the annular side wall 3b, and is horizontally long on the upper surface of the lower annular wall 4 at a portion protruding from the annular side wall 3. A narrow U-shaped flat portion 13 is provided which connects the upper surface portion 12 with the lower ends on both sides and the back side of the annular side wall 3 and the upper end of the lower annular wall 4.
  • the lower annular wall 4 is a rectangular annular wall with curved corners.
  • One end of the lower annular wall, specifically, the lower end (front side) in FIG. 1, is provided with an upper surface portion 12 connected to the upper end of the lower annular wall 4.
  • the upper surface portion 12 is a flat portion, and characters and the like can be written on the surface thereof with a writing instrument. Further, it is preferable that the surface of the upper surface portion 12 is a rough surface, specifically, a satin finish surface. By doing so, it becomes easier to write with a writing instrument or the like, and it becomes easier to visually recognize the written characters or the like.
  • the cell freezing pretreatment work plate 1 has an annular side wall 3 extending upward from the lower annular wall 4 of a portion other than the upper surface portion 12. Further, a narrow U-shaped flat portion 13 is provided which connects both side portions of the annular side wall 3 and the lower ends on the back side with the upper end of the lower annular wall 4. Therefore, a step portion is formed between the lower annular wall 4 and the annular side wall 3 by the upper surface portion 12 and the flat portion 13. The upper surface of this step portion serves as a mounting portion for the lid 5. As shown in FIG. 3, the annular side wall 3 is formed higher than the upper surface portion 12. In this embodiment, the annular side wall 3 is a rectangular annular wall with curved corners, as shown in FIGS. 1 to 4.
  • a working flat plate portion 2 for storing the treatment liquid, a second recess 15 for storing the treatment liquid, and a third recess 16 for storing the treatment liquid And a fourth recess 18 for storing the waste treatment liquid is provided.
  • the work flat plate portion 2 is provided at a position slightly lower than the upper end of the annular side wall 3, and has a substantially rectangular flat plate portion. It has become. Further, in this embodiment, the second flat plate portion 17 is provided, and the first concave portion 14 is formed in the second flat plate portion 17. Specifically, the second flat plate portion 17 is formed so as to be adjacent to the working flat plate portion 2, and the upper surface thereof is substantially the same height as the upper surface of the working flat plate portion 2.
  • the first recess 14 is a recess for storing the cell treatment liquid, and specifically, is a recess for storing the low-concentration treatment liquid containing a cell membrane-permeable cryoprotectant substance at a low concentration.
  • the cell freezing pretreatment plate 1 includes a first protruding portion 41 that protrudes upward from the bottom 6 inside the annular side wall 3, and the first protruding portion.
  • a second recess 15 is formed in 41.
  • the cell freezing pretreatment work plate 1 of this embodiment includes a second protruding portion 42 projecting upward from the inner bottom portion 6 of the annular side wall 3, and the second protruding portion 42 has a third recess 16. Is formed.
  • the second recess 15 and the third recess 16 have a flat, small circular bottom surface and a tapered side surface whose diameter decreases toward the bottom surface.
  • the second recess 15 and the third recess 16 have an inverted truncated cone shape (the cross-sectional area decreases toward the bottom surface).
  • the distance between the upper ends of the portion 42 (first recess 16) is preferably 1 to 5 mm, and particularly preferably 1.5 to 4 mm.
  • the second recess 15 is a recess for storing the cell treatment liquid, specifically, a recess for storing the high-concentration treatment liquid containing a cell membrane-permeable cryoprotectant substance at a high concentration.
  • the third recess 16 is a recess for storing the cell treatment liquid, specifically, a recess for storing the high-concentration treatment liquid containing a cell membrane-permeable cryoprotectant substance at a high concentration.
  • the concentration of the cell membrane-permeable cryoprotectant in the treatment liquid stored in the second recess 15 and the third recess 16 may be different.
  • the cell freezing pretreatment plate 1 is provided with a fourth recess 18 for storing the waste liquid, as shown in FIGS. 1 to 4.
  • the recess formed by the side surfaces of the protrusions 41 and 42, the inner surface of the annular side wall, and the bottom portion 6 is the fourth recess 18.
  • a first circular compartment 21 for placing the treatment liquid and a second circular compartment 22 for placing the treatment liquid are provided on the surface of the working flat plate portion 2, as shown in FIG. 7, a first circular compartment 21 for placing the treatment liquid and a second circular compartment 22 for placing the treatment liquid are provided.
  • a third circular compartment 23 for placing the treatment liquid is provided.
  • the first circular compartment 21 is a circular compartment for placing a treatment liquid containing no cell membrane permeable cryoprotectant
  • the second circular compartment 22 is a low concentration treatment of the cell membrane permeable cryoprotectant. It is a circular compartment for placing the liquid
  • the third circular compartment 23 is a circular compartment for placing the cell membrane-permeable cryoprotectant low-concentration treatment liquid.
  • the size (diameter) of each of the circular compartments 21, 22, 23 is preferably 3 to 8 mm, particularly preferably 4 to 7 mm.
  • the area of each of the circular compartments 21, 22, and 23 is preferably 7 to 50 mm 2 , and particularly preferably 12 to 40 mm 2 .
  • the circular compartments 21, 22, and 23 have substantially the same size, but they may be individually different. Further, it is preferable that a predetermined amount of the treatment liquid can be placed on each of the circular compartments 21, 22, and 23.
  • the amount of the treatment liquid that can be placed is preferably 10 to 50 ⁇ L, and particularly preferably 15 to 25 ⁇ L.
  • first circular section 21, the second circular section 22, and the third circular section 23 are close to each other.
  • the distance between the first circular section 21 and the second circular section 22 is preferably 1 to 5 mm, and particularly preferably 1.5 to 3 mm.
  • the third circular section 23 is close to the first circular section 21 and the second circular section 22, and is substantially equidistant from them. Is preferable. Specifically, as shown in FIG. 7, it is preferably located on the front side of the intermediate portion between the first circular section 21 and the second circular section 22.
  • the distance between the first circular section 21, the second circular section 22, and the third circular section 23 is preferably 1 to 5 mm, and particularly preferably 1.5 to 3 mm.
  • the outer edge 21a of the first circular section 21, the outer edge 22a of the second circular section 22, and the outer edge 23a of the third circular section 23 are annular. It is preferably a groove.
  • the outer edges 21a, 22a, 23a may be annular ribs.
  • the work plate portion 2 has a treatment liquid name and a placement amount to be placed on the first circular section 21. It has a first display unit 26 having a display. “BS” in the display unit 26 is a simplified display of “Basic Solution” and indicates a cell membrane permeable cryoprotectant-free treatment liquid, and the treatment liquid placed on the first circular compartment 21 is the cell membrane. It is a display that informs the operator that it is a permeable cryoprotectant-free treatment liquid, and "20 ⁇ L" attached next to it is a display that informs the operator of the loading amount.
  • BS cell membrane permeable cryoprotectant-free treatment liquid
  • those conventionally used are preferably used.
  • a cell culture basal solution for example, a cell culture solution containing HEPES [4- (2-HydroxyEthyl) -1-PiperazineEthaneSulfonic acid]
  • HEPES 4- (2-HydroxyEthyl) -1-PiperazineEthaneSulfonic acid
  • Those containing one or more cell membrane impermeable cryoprotectants selected from a kind of water-soluble cellulose and the like, and antibiotics such as gentamycin are suitable.
  • a second display having a treatment liquid name and a placement amount display to be placed on the second circular compartment 22 is displayed. It has a part 27.
  • “ES” on the display unit 27 is a simplified display of “Equilibration Solution” and indicates a low-concentration treatment solution containing a cell membrane-permeable cryoprotectant substance at a low concentration, and is placed on the second circular compartment 22. It is a display that informs the operator that the treatment liquid to be processed is a low-concentration treatment liquid, and "20 ⁇ L" attached next to it is a display that informs the operator of the loading amount.
  • “ES” on the display unit 28 is a simplified display of “Equilibration Solution” and indicates a low-concentration treatment solution containing a cell membrane-permeable cryoprotectant substance at a low concentration, and is placed on the third circular compartment 23. It is a display that informs the operator that the treatment liquid to be processed is a low-concentration treatment liquid, and "20 ⁇ L" attached next to it is a display that informs the operator of the loading amount.
  • ES low-concentration treatment solution containing a cell membrane-permeable cryoprotectant at a low concentration
  • a cell culture basal solution for example, a cell culture solution containing HEPES [4- (2-HydroxyEthyl) -1-PiperazineEthaneSulfonic acid]
  • Glycerol propylene glycol, dimethylsulfoside (DMSO)
  • DMSO dimethylsulfoside
  • ethylene glycol, butanediol and other cell membrane permeable cryoprotectants are added at low concentrations, as well as shoe cloth, trehalose, percol, polyethylene glycol, polyvinylpyrrolidone,
  • a cell membrane impermeable cryoprotectant such as bovine serum albumin, ficol, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, and
  • this ES may also contain an antibiotic such as gentamicin.
  • the content of the cell-penetrating cryoprotectant in this ES is the content of the cell-penetrating cryoprotectant in "VS" (a high-concentration treatment solution containing the cell-penetrating cryoprotectant at a high concentration) described later. It is preferably 20 to 70%, and particularly preferably 30 to 60%.
  • the cell freezing pretreatment work plate 1 has a fourth display unit 29 having a treatment liquid name and a storage amount display stored in the first recess 14.
  • “ES” on the display unit 29 is a simplified display of “Equilibration Solution” and indicates a low-concentration treatment solution containing a cell membrane-permeable cryoprotectant substance at a low concentration, and is stored (injected) in the first recess 14. It is a display that informs the operator that the treatment liquid is a low-concentration treatment liquid, and "300 ⁇ L" attached next to the display is a display that informs the operator of the injection amount.
  • the cell freezing pretreatment work plate has a fifth display unit 43 and a third recess having a treatment liquid name and a storage amount display stored in the second recess 15, as in the plate 1a shown in FIG. It may have a sixth display unit 44 having a processing liquid name and a storage amount display stored in 16.
  • the fourth recess is formed into a recess 18a which is the second recess side and a third recess side by the partition portion 46. It may be divided into recesses 18b.
  • VS on the display units 43 and 44 is a simplified display of “Vitrification Solution” and indicates a high-concentration treatment solution containing a cell membrane-permeable cryoprotectant substance at a high concentration, and the second recesses 15 and 3 It is a display that informs the operator that the treatment liquid stored (injected) in the recess 16 is a high-concentration treatment liquid, and "300 ⁇ L" attached next to it is a display that informs the operator of the injection amount. It has become.
  • VS high-concentration treatment solution containing a cell membrane-permeable cryoprotectant at a high concentration
  • a cell culture basal solution for example, a cell culture solution containing HEPES [4- (2-HydroxyEthyl) -1-PiperazineEthaneSulfonic acid]
  • Glycerol propylene glycol, dimethylsulfoside (DMSO)
  • DMSO dimethylsulfoside
  • ethylene glycol, butanediol and other cell membrane permeable cryoprotectants are added at high concentrations, and shoe cloth, trehalose, percol, polyethylene glycol, polyvinylpyrrolidone
  • Those containing a cell membrane impermeable cryoprotectant such as bovine serum albumin, ficol, hydroxypropyl cellulose, hydroxypropyl methyl cellulose, and hydroxy
  • this VS may also contain an antibiotic such as gentamicin.
  • the content of the cell membrane-permeable cryoprotectant in this VS is the content of the cell membrane-permeable cryoprotectant in the above-mentioned "ES" (a low-concentration treatment solution containing the cell membrane-permeable cryoprotectant at a low concentration). It is preferably 1.5 to 3 times, and particularly preferably 1.7 to 2.5 times.
  • the surface of the work flat plate portion 2 has a first circular compartment 21 from the second circular compartment 22. It has a first arrow display 24 extending toward the first arrow display 24 and a second arrow display 25 extending from the third circular section 23 toward the first arrow display 24.
  • the second arrow display 25 may extend toward the first circular section 21.
  • the first step order display (1) is displayed on the surface of the work plate portion 2 in the vicinity of the first arrow display (1).
  • a second step order display (2) is provided in the vicinity of the second arrow display, and as shown in FIG. 1, a third step order display (3) is provided on the second flat plate portion 17. I have.
  • the first step time display is displayed near the first step order display (1), and the second step time display is displayed near the second step order display (2).
  • the step time display is provided in the vicinity of the third step order display (3), and a third step time display is provided.
  • a second flat plate portion 17 having a first recess 14 is located next to (right side) the working flat plate portion 2.
  • the second concave portion 15, the third concave portion 16 and the fourth concave portion 18 are located on the front side of the working flat plate portion 2 and the second flat plate portion 17, whereby the rectangular work is performed.
  • a surface is formed.
  • the central portion of the rectangular work surface is a work order display 45 (1, 2, 3,) indicating the work order of the work flat plate portion 2, the first recess 14, the second recess 15, and the third recess 16. 4) is provided.
  • the work order display 3 and 4 may be reversed.
  • the cell freeze pretreatment working plate has a lid that simultaneously covers the working flat plate portion 2, the first recess 14, the second recess 15, and the third recess 16. It is preferable to have 5.
  • the lid 5 of this embodiment covers the entire rectangular working surface described above, and the upper surface portion 12 is exposed when the lid 5 is fitted. ing. Therefore, the lid 5 does not interfere with work such as writing characters on the upper surface portion 12.
  • the lid 5 of this embodiment has a top plate portion 51 and an annular side wall 52 extending below the top plate portion 51.
  • the annular side wall 52 is provided with a plurality of sets of slits 53 facing the side surfaces.
  • ribs 54 facing each other are provided on the inner upper surface of the lid 5.
  • the cell freezing pretreatment plate 1 and lid 5 are formed of a synthetic resin material. It is desirable that the plate 1 and the lid 5 for the cell freezing pretreatment work have high transparency, and a transparent hard synthetic resin is suitable.
  • Transparent hard synthetic resins include styrene resins such as polystyrene and SBS, polyolefins such as polycarbonate and acrylonitrile resins, polyolefins such as polypropylene and polyethylene, polyvinyl chloride, and polyesters such as PMMA (polymethylmethacrylate) polyethylene terephthalate and polybutylene terephthalate. It is preferable to use a resin or the like.
  • the cell freeze pretreatment work plate 1b shown in FIG. 11 will be described.
  • the basic configuration of the plate 1b is the same as that of the plate 1 described above.
  • the difference between the two is the arrangement position of the second recess 15, the third recess 16 and the fourth recess 18 with respect to the working flat plate portion 2 and the first recess 14.
  • a second flat plate portion 17 having a first recess 14 is located next to the work flat plate portion 2 (right side), and next to the second flat plate portion 17 (right side).
  • the second recess 15, the third recess 16, and the fourth recess 18 are located therein, and a horizontally long rectangular working surface is formed by these. Therefore, in the plate 1b, the lower annular wall 4a and the annular side wall 3a are also horizontally long rectangular, and the upper surface portion 12 is also horizontally long.
  • the plate 1b is also provided with a narrow flat portion 13 connecting both side portions of the annular side wall 3a and the lower end on the back side with the upper end of the lower annular wall 4a.
  • the plate 1b is also provided with a work order display (1, 2, 3, 4) indicating the work order of the work flat plate portion 2, the first recess 14, the second recess 15, and the third recess 16. Has been done.
  • the cell freeze pretreatment work plate 1c of the embodiment of the present invention shown in FIG. 12 will be described.
  • the basic configuration of the plate 1c is the same as that of the plate 1 described above.
  • the difference between the two is the configuration of the working flat plate portion 2, the arrangement position of the working flat plate portion 2, the first recess 14, the second recess 15, the third recess 16, and the fourth recess 18.
  • the working plate portion 2a is larger than the working plate portion 2 of the plate 1 described above. Then, on the surface of the working flat plate portion 2a, an enlargement surrounding the first circular section 21, the second circular section 22, the third circular section 23, and the first circular section 21. It has an enlarged second circular section 62 that surrounds the first circular section 61, the second circular section 22, and an enlarged third circular section 63 that surrounds the third circular section 23. ..
  • the size, arrangement, and the like of the first circular section 21, the second circular section 22, and the third circular section 23 are the same as those of the plate 1 described above.
  • the enlarged first circular section 61 has a larger diameter than the first circular section 21, and is not centered on the first circular section 21, but the first circular section 21 is enlarged and the first circular section 21 is expanded. It surrounds the compartment 61 in a state of being close to the inner side and the outer edge or in contact with the outer edge.
  • the enlarged second circular section 62 also has a larger diameter than the second circular section 22, and the second circular section 22 is expanded instead of being centered on the second circular section 22. It surrounds the compartment 62 in a state of being close to or in contact with the outer edge of the compartment 62.
  • the enlarged third circular section 63 also has a larger diameter than the third circular section 23, and is not centered on the third circular section 23, but the third circular section 23 is expanded to have a third circular shape. It surrounds the compartment 63 in a state of being close to or in contact with the outer edge of the compartment 63.
  • the enlarged first circular compartment 61 is a circular compartment for placing a treatment liquid containing no cell membrane permeable cryoprotectant
  • the enlarged second circular compartment 62 is a low concentration treatment of the cell membrane permeable cryoprotectant. It is a circular compartment for placing the liquid
  • the expanded third circular compartment 63 is a circular compartment for placing the cell membrane-permeable cryoprotectant low-concentration treatment liquid.
  • the diameter of each of the enlarged circular compartments 61, 62, 63 is preferably 1.5 to 3 times the diameter of each of the circular compartments 21, 22, 23, and particularly 1.7 to 2. It is preferably 5 times.
  • the area of each of the enlarged circular compartments 61, 62, 63 is preferably 2 to 10 times the area of each of the circular compartments 21, 22, 23, and particularly 3 to 7 times. It is preferable to have.
  • the cell freezing pretreatment working plate 1c of this example is placed on the working flat plate portion 2a on the first circular compartment 21 and the enlarged first circular compartment 61.
  • It has a first display unit 26a having a processing liquid name and a loading amount display (two displays).
  • “BS” in the display unit 26a is a simplified display of “Basic Solution” and indicates a treatment solution containing no cell membrane permeable cryoprotectant, and “20 ⁇ L” attached in the vicinity thereof is the first circular compartment 21.
  • “100 ⁇ L” indicates the amount placed on the enlarged first circular section 61 to inform the operator of the amount placed on the enlarged first circular section 61.
  • the enlarged first circular compartment 61 is used, and in the case of single cell treatment, the first circular compartment 21 is used.
  • the cell freezing pretreatment working plate 1c of this example is mounted on the working flat plate portion 2a on the second circular compartment 22 and the enlarged second circular compartment 62. It has a second display unit 27a having a treatment liquid name to be placed and a placement amount display (two displays). “ES” in the display unit 27a indicates a low-concentration treatment liquid containing a cell membrane-penetrating cryoprotectant substance at a low concentration, and “20 ⁇ L” attached in the vicinity thereof is a second circular compartment 22. “100 ⁇ L” indicates the amount placed on the enlarged second circular compartment 62 to inform the operator of the amount placed on the enlarged second circular section 62. When treating a plurality of cells at the same time, the expanded second circular compartment 62 is used, and in the case of single cell treatment, the second circular compartment 22 is used.
  • the cell freezing pretreatment working plate 1c of this example is placed on the working flat plate portion 2a on the third circular compartment 23 and the enlarged third circular compartment 63.
  • It has a third display unit 28a having a treatment liquid name to be placed and a placement amount display (two displays).
  • “ES” in the display unit 28a indicates a low-concentration treatment liquid containing a cell membrane-permeable cryoprotectant at a low concentration, and “20 ⁇ L” attached in the vicinity thereof is a third circular compartment 23.
  • “100 ⁇ L” indicates the amount placed on the enlarged third circular section 63 to inform the operator of the amount placed on the third circular section 63.
  • the expanded third circular compartment 63 is used, and in the case of single cell treatment, the third circular compartment 23 is used.
  • the first recess 14, the second recess 15, the third recess 16, and the fourth recess 18 are arranged on the front side of the working flat plate portion 2a.
  • the plate 1c of this embodiment also has a treatment liquid name and a storage amount display to be stored (injected) in the first recess 14, the second recess 15, and the third recess 16.
  • the working flat plate portion 2, the first recess 14, the second recess 15, the third recess 16, and the fourth recess 18 are surrounded by an annular side wall 3b, and the upper surface thereof is an annular side wall 3b. It is located slightly below the upper end of.
  • the lower annular wall 4b has a substantially rectangular shape, and like the plate 1, the lower annular wall of the portion larger than the annular side wall 3b and protruding from the annular side wall 3b.
  • a horizontally long upper surface portion 12 and a narrow flat portion 13 connecting both side portions of the annular side wall 3b and the lower end on the back side and the upper end of the lower annular wall 4b are provided.
  • the cell freeze pretreatment work plate 1d of the example shown in FIG. 13 will be described.
  • the basic configuration of the plate 1d is the same as that of the plate 1c described above.
  • the difference between the two is the arrangement position of the working flat plate portion 2b, the first recess 14, the second recess 15, the third recess 16, and the fourth recess 18.
  • the first recess 14, the second recess 15, and the third recess 16 are arranged in this order on the side portion (specifically, the right side) of the working flat plate portion 2b from the back side.
  • a fourth recess 18 is provided so as to surround the second recess 15 and the third recess 16.
  • the plate 1d of this embodiment also has a treatment liquid name and a storage amount display to be stored (injected) in the first recess 14, the second recess 15, and the third recess 16.
  • the working flat plate portion 2b, the first recess 14, the second recess 15, the third recess 16, and the fourth recess 18 are surrounded by the annular side wall 3c, and the upper surface thereof is the annular side wall 3c.
  • the lower annular wall 4c has a substantially rectangular shape, and similarly to the plate 1, the lower annular wall 4c is larger than the annular side wall 3c and protrudes from the annular side wall 3c.
  • a horizontally long upper surface portion 12 both side portions of the annular side wall 3c, and a narrow flat portion 13 connecting the lower ends on the back side and the upper end of the lower annular wall 4c are provided.
  • the cell freeze pretreatment work plate 1e of the example shown in FIG. 14 will be described.
  • the basic configuration of the plate 1e is the same as that of the plate 1c described above. The difference between the two is the arrangement position of the working flat plate portion 2c, the first recess 14, the second recess 15, the third recess 16, and the fourth recesses 18a and 18b.
  • the lower annular wall 4d and the annular side wall 3d have a substantially pentagonal shape with the back side having a substantially triangular shape, and the lower annular wall 4d is formed from the annular side wall 3d as in the plate 1.
  • the first recess 14 is arranged on the back side of the working flat plate portion 2c, and the second recess 15 and the second recess 15 and the front side portion of one (left side) of the working flat plate portion 2c are arranged.
  • a fourth recess 18a is arranged, and a third recess 16 and a fourth recess 18b are arranged on the front side of the other (right side) of the working flat plate portion 2c.
  • the plate 1e of this embodiment also has a treatment liquid name and a storage amount display to be stored (injected) in the first recess 14, the second recess 15, and the third recess 16.
  • the working flat plate portion 2c, the first recess 14, the second recess 15, the third recess 16, and the fourth recesses 18a and 18b are surrounded by the annular side wall 3d, and the upper surface thereof is annular. It is located slightly below the upper end of the side wall 3d.
  • cells to be frozen for example, embryos
  • BS treatment solution containing no cell membrane permeable cryoprotectant
  • ES low concentration treatment solution containing cell membrane permeable cryoprotectant at low concentration
  • VS cell membrane
  • a high-concentration treatment solution containing a high concentration of a permeable cryoprotectant substance is prepared.
  • a predetermined amount (300 ⁇ L) of ES is injected into the first recess 14 of the plate 1 according to the indication 29, and a predetermined amount (300 ⁇ L) of VS is injected into the second recess 15 and the third recess 16.
  • the cells to be frozen are collected with a micropipette or the like and transplanted to the BS placed in the first circular compartment 21.
  • the second circular section portion 22 and the second circular section portion 22 and the second circular section portion 22 and the second in the member (for example, a pipette) used for transplantation are connected.
  • the second circular section 22 and the first circular section 21 communicate with each other.
  • the display unit 37 it is left for 3 minutes.
  • ES is gradually mixed with the BS into which the cells of the first circular compartment 21 are transplanted, and the concentration of the low-concentration treatment liquid in the treatment liquid surrounding the cells is increased to form a mixed portion.
  • the third circular section portion 23 is described above with the member (for example, a pipette) used for transplantation. Connect to the mixing part of. As a result, the second circular section 22, the first circular section 21, and the third circular section 23 communicate with each other. Then, according to the display unit 38, it is left for 3 minutes. By this operation, the low-concentration treatment liquid concentration of the treatment liquid surrounding the target cells is gradually and further increased. By doing so, the concentration of the cell membrane-permeable cryoprotectant substance gradually increases in the treatment solution surrounding the cells to be frozen, so that the equilibration treatment of the cells can be proceeded without damaging the cells. By the above operation, the equilibration first step process is completed.
  • the member for example, a pipette
  • the first circular compartment 21 for placing the cell membrane-permeable cryoprotectant-free treatment liquid and the low-concentration treatment liquid are placed on the surface of the working flat plate portion 2.
  • the second circular section 22 and the third circular section 23 for placing the low-concentration treatment liquid are provided, and the first circular section, the second circular section, and the third circular section 23 are provided. Since the circular compartments are close to each other, the above-mentioned preparation for equilibration and the work thereof can be easily and surely performed.
  • the cells treated in the first step of equilibration in the working flat plate portion 2 as described above were sucked and collected by a micropipette or the like, and placed on the liquid surface of ES injected into the first recess 14. After that, leave it for 9 minutes.
  • the cells placed on the surface of the ES can be observed to contract while settling within 30 seconds, and further, wait for the volume of the embryo that has once greatly contracted to completely recover. This completes the second step of equilibration.
  • the cells in the first recess 14 are aspirated and collected by a micropipette or the like, and placed on the surface of the second recess 15 in which VS is injected.
  • the carry-in of the ES liquid into the VS liquid of the second recess 15 is minimized.
  • the ES in the micropipette is discarded in the fourth recess 18 for storing the waste treatment liquid.
  • fresh VS is sucked and discarded from the edge of the second recess 15, and the micropipette is co-washed with VS in the first recess 14.
  • the VS in the micropipette is discarded in the fourth recess 18 for storing the waste treatment liquid, and the fresh VS injected in the third recess 16 is sucked.
  • the cells in the second recess 15 are sucked by the micropipette sucked with fresh VS, and the cells are put into the third recess 16 in which the VS is injected.
  • Sufficient pipetting excreting the embryo from the pipette into the VS and stirring the area around the embryo several times quickly
  • the cells to be frozen are collected at the tip of the micropipette, and the living cell holding portion (not shown) of the living cell cryopreservation tool (not shown) is placed together with a small amount of VS under a microscope.
  • the living cell holding portion of the living cell cryopreservation tool to which the cells are attached is immersed in liquid nitrogen prepared in advance and frozen (vitrified).
  • the biological cell cryopreservation tool to which the cells are attached is inserted into the tubular member (not shown), and the tubular storage member containing the biological cell cryopreservation tool is stored in the storage container (not shown). Then, the storage container is placed in a liquid nitrogen tank and stored.
  • the cell freeze pretreatment working plate of the present invention is as follows.
  • a plate for cell freeze pretreatment work the plate includes a working flat plate portion, a first recess for storing a low-concentration treatment liquid containing a cell membrane-permeable cryoprotectant at a low concentration, and the like.
  • a fourth recess for storing waste liquid, and further, on the surface of the working flat plate portion, a first circular compartment for placing a treatment liquid containing no cell membrane-permeable cryoprotectant, and a circular compartment.
  • a second circular compartment for placing the low-concentration treatment liquid and a third circular compartment for placing the low-concentration treatment liquid are provided, and the first circular compartment and the second circular compartment are provided.
  • the circular section and the third circular section are close to each other, and further, on the surface of the working flat plate portion, an enlarged first circular section surrounding the first circular section.
  • For cell freezing pretreatment work which has an enlarged second circular compartment that surrounds the second circular compartment, and an enlarged third circular compartment that surrounds the third circular compartment. plate.
  • an appropriate amount of the cell membrane permeable cryoprotectant-free treatment liquid is placed (dropped) on the first circular compartment, and an appropriate amount of the low-concentration treatment liquid is placed on the second circular compartment (). (Drop), and an appropriate amount of low-concentration treatment liquid is placed (dropped) on the third circular section.
  • the cells to be frozen are transplanted into the cell membrane-permeable cryoprotectant-free treatment solution, and subsequently, the second circular section and the first circular section are formed by the member (for example, pipette) used for the transplantation.
  • the low-concentration treatment liquid gradually mixes with the non-concentration treatment liquid, and the concentration of the low-concentration treatment liquid in the treatment liquid surrounding the target cells increases.
  • the low-concentration treatment liquid is gradually mixed.
  • the low-concentration treatment solution concentration of the treatment solution that mixes with the part and surrounds the target cells gradually increases.
  • the concentration of the cell membrane-permeable cryoprotectant substance gradually increases in the treatment solution surrounding the cells to be frozen, so that the target cells can be equilibrated with a good cell membrane-permeable cryoprotectant substance. ..
  • a first circular compartment for placing a cell membrane-permeable cryoprotectant-free treatment liquid and a second circular compartment for placing a low-concentration treatment liquid are provided on the surface of the working flat plate portion. Since it is provided with a third circular section for placing the low-concentration treatment liquid, the first circular section, the second circular section, and the third circular section are close to each other. , The above-mentioned preparation for equilibration, and further, good equilibration treatment can be easily and surely performed. Further, when treating a plurality of cells at the same time, an enlarged circular compartment is used, and in the case of single cell treatment, a small circular compartment located in the expanded circular compartment is used. Therefore, it can be used properly depending on the number of treated cells.
  • the embodiment of the above-mentioned cell freezing pretreatment work plate is as follows. (2)
  • the working flat plate portion is mounted on a first display portion having a treatment liquid name and a loading amount display placed on the first circular compartment portion and the second circular compartment portion.
  • a second display unit having a processing liquid name and a loading amount display to be placed, and a third display unit having a processing liquid name and a loading amount display to be placed in the third circular section.
  • the cell freeze pretreatment work plate has a fourth display portion having a treatment liquid name and a storage amount display stored in the first recess. The cell freeze pretreatment working plate described.
  • a first arrow display extending from the second circular compartment portion toward the first circular compartment portion and the third circular compartment portion
  • the cell freeze pretreatment working plate according to any one of (1) to (3) above, which has the first arrow display or the second arrow display extending toward the first circular compartment. .. (5)
  • the cell freeze pretreatment work plate is provided with a lid that simultaneously covers the work flat plate portion, the first recess, the second recess, and the third recess (1). Or the plate for cell freezing pretreatment work according to any one of (4).
  • the cell freezing pretreatment working plate includes a bottom portion, an annular side wall extending upward from the bottom portion, and a protruding portion protruding upward from the bottom portion, and the protruding portion has the second recess or the second recess.
  • Work plate (7)
  • the cell freeze pretreatment working plate has a bottom, an annular side wall extending upward from the bottom, a first protruding portion protruding upward from the bottom, and a second protruding portion upward from the bottom.
  • the first protrusion comprises the second recess
  • the second protrusion comprises the third recess, the side surface of the protrusion, the inner surface of the annular side wall, and the said.
  • the cell freeze pretreatment work plate according to any one of (1) to (6) above, wherein the fourth recess is formed by the bottom portion.
  • the cell freezing pretreatment working plate includes a second flat plate portion, and the first concave portion is formed in the second flat plate portion.
  • the working flat plate portion includes a first display unit having a treatment liquid name and a loading amount display to be placed on the first circular section and the enlarged first circular section, and the above.
  • the cell freeze pretreatment working plate of the present invention is as follows. (10) A cell freeze pretreatment work plate, which is a working flat plate portion, a first recess for storing a treatment liquid, a second recess for storing a treatment liquid, and a treatment liquid storage. A third recess for storing the waste treatment liquid and a fourth recess for storing the waste treatment liquid are provided, and further, on the surface of the working flat plate portion, a first circular partition portion for placing the treatment liquid and a treatment liquid are provided. A second circular section for mounting and a third circular section for placing the treatment liquid are provided, and the first circular section, the second circular section, and the second circular section are provided.
  • the circular compartments of 3 are close to each other, and further, on the surface of the working flat plate portion, an enlarged first circular compartment surrounding the first circular compartment and the second circle
  • a cell freeze pretreatment work plate having an enlarged second circular compartment surrounding the shaped compartment and an enlarged third circular compartment surrounding the third circular compartment.
  • the working flat plate portion is mounted on a first display portion having a treatment liquid name and a loading amount display placed on the first circular compartment portion and the second circular compartment portion. It has a second display unit having a treatment liquid name and a placement amount display to be placed, and a third display unit having a treatment liquid name and a placement amount display to be placed in the third circular compartment.
  • the working flat plate portion includes a first display unit having a treatment liquid name and a loading amount display to be placed on the first circular section and the enlarged first circular section, and the above.
  • a second display unit having a treatment liquid name and a loading amount display mounted on the second circular compartment and the enlarged second circular compartment, and the third circular compartment and the enlarged second. 3.

Landscapes

  • Life Sciences & Earth Sciences (AREA)
  • Health & Medical Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Wood Science & Technology (AREA)
  • Zoology (AREA)
  • General Health & Medical Sciences (AREA)
  • Environmental Sciences (AREA)
  • Dentistry (AREA)
  • Chemical & Material Sciences (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Biomedical Technology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Sustainable Development (AREA)
  • Genetics & Genomics (AREA)
  • Microbiology (AREA)
  • Biotechnology (AREA)
  • Molecular Biology (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Physics & Mathematics (AREA)
  • Thermal Sciences (AREA)
PCT/JP2020/029814 2019-08-05 2020-08-04 細胞凍結前処理作業用プレート Ceased WO2021025017A1 (ja)

Priority Applications (3)

Application Number Priority Date Filing Date Title
EP20850279.9A EP4012013A4 (en) 2019-08-05 2020-08-04 PRETREATMENT PLATE FOR CELL CRYOPRESERVATION
JP2021537319A JP7607339B2 (ja) 2019-08-05 2020-08-04 細胞凍結前処理作業用プレート
US17/592,785 US12402620B2 (en) 2019-08-05 2022-02-04 Cell cryopreservation pretreatment operation plate

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
JP2019143967 2019-08-05
JP2019-143967 2019-08-05

Related Child Applications (1)

Application Number Title Priority Date Filing Date
US17/592,785 Continuation US12402620B2 (en) 2019-08-05 2022-02-04 Cell cryopreservation pretreatment operation plate

Publications (1)

Publication Number Publication Date
WO2021025017A1 true WO2021025017A1 (ja) 2021-02-11

Family

ID=74503007

Family Applications (1)

Application Number Title Priority Date Filing Date
PCT/JP2020/029814 Ceased WO2021025017A1 (ja) 2019-08-05 2020-08-04 細胞凍結前処理作業用プレート

Country Status (4)

Country Link
US (1) US12402620B2 (cg-RX-API-DMAC7.html)
EP (1) EP4012013A4 (cg-RX-API-DMAC7.html)
JP (1) JP7607339B2 (cg-RX-API-DMAC7.html)
WO (1) WO2021025017A1 (cg-RX-API-DMAC7.html)

Cited By (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022184050A1 (zh) * 2021-03-03 2022-09-09 深圳拜尔洛克生物技术有限公司 用于生物组织冷冻保存或解冻复苏的生物芯片
WO2023002974A1 (ja) 2021-07-21 2023-01-26 株式会社北里コーポレーション 生体細胞処理作業用プレートおよび生体細胞凍結前処理作業用キット
JP2025075380A (ja) * 2023-10-31 2025-05-15 医療法人浅田レディースクリニック 複数ウエルを備えるディッシュ

Citations (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000189155A (ja) 1998-12-25 2000-07-11 Livestock Improvement Association Of Japan Inc 哺乳動物胚または卵子の保存方法並びに凍結胚または卵子の融解希釈方法
JP2002315573A (ja) 2001-04-18 2002-10-29 Kitazato Supply:Co Ltd 卵凍結保存用具および筒状部材保持器具
JP2015053876A (ja) * 2013-09-11 2015-03-23 大日本印刷株式会社 培養容器
JP2016099547A (ja) * 2014-11-25 2016-05-30 大日本印刷株式会社 表示部材、培養容器、及び培養容器キット
WO2016190322A1 (ja) 2015-05-25 2016-12-01 大日本印刷株式会社 細胞処理容器
JP2017060428A (ja) * 2015-09-25 2017-03-30 大日本印刷株式会社 細胞挙動評価用基板、細胞挙動評価用容器及び細胞挙動評価方法

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2010003423A2 (en) * 2008-07-05 2010-01-14 Unisense Fertilitech A/S One to one identification system
JP4724854B2 (ja) * 2009-02-09 2011-07-13 大日本印刷株式会社 細胞培養容器
US9169460B2 (en) * 2009-05-19 2015-10-27 Lifeglobal Group Llc Flooding dish and method for changing media in the dish in the preparation of mammalian specimen culture and for cryo-preservation, freezing, vitrification and the thawing and warming of such specimens
JP6349847B2 (ja) * 2013-03-26 2018-07-04 大日本印刷株式会社 細胞培養容器
AU2014276229B2 (en) * 2013-06-07 2019-11-21 Corning Incorporated Culture vessel and culture method
US20150329814A1 (en) * 2014-05-16 2015-11-19 Michael D. Cecchi Apparatus for long-term uninterrupted safe culturing of embryos, biological specimens in a controlled environment having improved imaging capabilities

Patent Citations (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
JP2000189155A (ja) 1998-12-25 2000-07-11 Livestock Improvement Association Of Japan Inc 哺乳動物胚または卵子の保存方法並びに凍結胚または卵子の融解希釈方法
JP2002315573A (ja) 2001-04-18 2002-10-29 Kitazato Supply:Co Ltd 卵凍結保存用具および筒状部材保持器具
WO2002085110A1 (en) 2001-04-18 2002-10-31 Kabushikikaisha Kitazato Supply Egg freezing preservation tool, and cylindrical member holding tool
JP2015053876A (ja) * 2013-09-11 2015-03-23 大日本印刷株式会社 培養容器
JP2016099547A (ja) * 2014-11-25 2016-05-30 大日本印刷株式会社 表示部材、培養容器、及び培養容器キット
WO2016190322A1 (ja) 2015-05-25 2016-12-01 大日本印刷株式会社 細胞処理容器
JP2017118884A (ja) 2015-05-25 2017-07-06 大日本印刷株式会社 細胞処理容器
JP2017060428A (ja) * 2015-09-25 2017-03-30 大日本印刷株式会社 細胞挙動評価用基板、細胞挙動評価用容器及び細胞挙動評価方法

Non-Patent Citations (3)

* Cited by examiner, † Cited by third party
Title
ANONYMOUS: "KITAZAto Oocyte Cryo plate", 13 February 2019 (2019-02-13), XP055791869, Retrieved from the Internet <URL:https://www.kitazato.co.jp/ja/pdf/cryo/Flyer-JP-Oocyte%20Cryo%20Plate20190213%20for%20mail.pdf> [retrieved on 20200916] *
SATOSHI UENO; JUN SHIMAMURA; YUKIKO NAKAJO; HIDEMINE MIYAI; AKIKO YABUUCHI: "Vitrification preservation of human embryos and eggs - Fishing of good sleep / eggs by the Cryotop method. Melting -", J. CLIN. EMBRYOLOGIST, vol. 19, no. 2, 2017, pages 132 - 133, XP009526742, ISSN: 1349-0834 *
See also references of EP4012013A4

Cited By (7)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2022184050A1 (zh) * 2021-03-03 2022-09-09 深圳拜尔洛克生物技术有限公司 用于生物组织冷冻保存或解冻复苏的生物芯片
JP2024508150A (ja) * 2021-03-03 2024-02-22 深▲セン▼拜爾洛克生物技術有限公司 生体組織の凍結保存または解凍蘇生に用いられるバイオチップ
JP7646245B2 (ja) 2021-03-03 2025-03-17 深▲セン▼拜爾洛克生物技術有限公司 生体組織の凍結保存または解凍蘇生に用いられるバイオチップ
US12648558B2 (en) 2021-03-03 2026-06-09 Shen Zhen Biorocks Biotechnology Company Limited Biochip for cryopreservation or thawing and resuscitation of biological tissue
WO2023002974A1 (ja) 2021-07-21 2023-01-26 株式会社北里コーポレーション 生体細胞処理作業用プレートおよび生体細胞凍結前処理作業用キット
JPWO2023002974A1 (cg-RX-API-DMAC7.html) * 2021-07-21 2023-01-26
JP2025075380A (ja) * 2023-10-31 2025-05-15 医療法人浅田レディースクリニック 複数ウエルを備えるディッシュ

Also Published As

Publication number Publication date
US20220151223A1 (en) 2022-05-19
JPWO2021025017A1 (cg-RX-API-DMAC7.html) 2021-02-11
JP7607339B2 (ja) 2024-12-27
EP4012013A1 (en) 2022-06-15
EP4012013A4 (en) 2022-10-19
US12402620B2 (en) 2025-09-02

Similar Documents

Publication Publication Date Title
US12402620B2 (en) Cell cryopreservation pretreatment operation plate
US6899850B2 (en) Method and basket apparatus for transporting biological samples
JP6846054B2 (ja) 液中操作型ガラス化凍結保存方法
Vajta et al. Sterile application of the open pulled straw (OPS) vitrification method
JP2016507241A (ja) 細胞を培養するための構造体
CN111700064B (zh) 一种细胞冷冻辅助装置
WO2014088514A1 (en) A method of vitrification
Reed Culture systems: embryo density
CN113340699A (zh) 类器官组织冰冻切片包埋试剂盒及包埋方法
JPWO2021025017A5 (cg-RX-API-DMAC7.html)
JP2021023296A (ja) 細胞凍結前処理作業用プレート
Crook et al. Cryobanking pluripotent stem cells
CN210929356U (zh) 一种封闭式卵巢组织冷冻装置
WO2010124663A2 (en) Method for adding, removing or exchange a liquid medium in culturing biological cells and culture device
CN212325242U (zh) 一种细胞冷冻辅助装置
US20080248563A1 (en) Specimen container for the micro manipulation and biopsy in in-vitro fertilization
JP3246742U (ja) 心筋細胞単離キット
EP4375358A1 (en) Biological cell processing work plate and biological cell pre-freezing processing work kit
US20210298291A1 (en) Auxiliary device for cryopreservation
Schiewe Quality Control Factors Influencing the Successful and Reliable Implementation of Oocyte and Embryo
KR20200117919A (ko) 각각의 수정란을 공동배양 할 수 있는 배양 접시
JP4498260B2 (ja) ガラス化用具のシーリング方法
AU2011202585B2 (en) Method and basket apparatus for transporting biological samples
AU2011202584B2 (en) Method and basket apparatus for transporting biological samples
Amer et al. Cryopreservation of rare ejaculate and testicular spermatozoa, a novel simple technique; the culture dish slice freezing: A pilot study.

Legal Events

Date Code Title Description
121 Ep: the epo has been informed by wipo that ep was designated in this application

Ref document number: 20850279

Country of ref document: EP

Kind code of ref document: A1

ENP Entry into the national phase

Ref document number: 2021537319

Country of ref document: JP

Kind code of ref document: A

NENP Non-entry into the national phase

Ref country code: DE

ENP Entry into the national phase

Ref document number: 2020850279

Country of ref document: EP

Effective date: 20220307